The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents

New England Journal of Medicine

Volumn 321, Issue 9, 1989, Pages 580-585

  Rocchini, Albert P ^a   Key, Jane ^a   Bondie, Diane ^a   Chico, Robin ^a   Moorehead, Catherine ^a   Katch, Victor ^a   Martin, Monica ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0024323773     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198908313210905     Document Type: Article

References (45)

1. Dahl LK, Silver L, Christie RW. The role of salt in the fall of blood pressure accompanying reduction in obesity. N Engl J Med 1958; 258: 1186–92.
2. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction in the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978; 298: 1–6.
3. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930–3.
4. Rocchini AP, Katch V, Anderson J, et al. Blood pressure in obese adolescents: effect of weight loss. Pediatrics 1988; 82: 16–23.
5. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980; 69: 334–44.
6. Skrabal F, Herholz H, Neumayr M, et al. Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 1984; 6: 152–8.
7. Luft FC, Weinberger MH, Grim CE, Fineberg NS, Miller JZ. Sodium sensitivity in normotensive human subjects. Ann Intern Med 1983; 98: 758–62.
8. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8: Suppl II: II-127–II-134.
9. Sullivan JM, Prewitt RL, Ratts TE, Joseph JA, Connor MJ. Hemodynamic characteristics of sodium-sensitive human subjects. Hypertension 1987; 9: 398–406.
10. Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986; 57: 613–8.
11. Ellis CN, Julius S. Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J 1973; 35: 450–5.
12. Hinderliter AL, Fitzpatrick MA, Schork N, Julius S. Research utility of noninvasive methods for measurement of cardiac output. Clin Pharmacol Ther 1987; 41: 419–25.
13. Alverson DC, Eldridge M, Dillon T, Yabek SM, Berman W Jr. Noninvasive pulsed Doppler determination of cardiac output in neonates and children. J Pediatr 1982; 101: 46–50.
14. Katch F, Michael ED, Horvath SM. Estimation of body volume by underwater weighing: description of a simple method. J Appl Physiol 1967; 23: 811–3.
15. Wilmore JH. A simplified method for determination of residual lung volumes. J Appl Physiol 1969; 27: 96–100.
16. Anlunes JR, Dale SL, Melby JC. Simplified radioimmunoassay for aldosterone using antisera to aldosterone-γ-lactone. Steroids 1976; 28: 621–30.
17. Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981; 28: 467–75.
18. Sheng HP, Huggins RA. A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 1979; 32: 630–47.
19. Sims EA. Mechanisms of hypertension in the syndromes of obesity. Int J Obes 1981; Suppl 1: 9–18.
20. Gillum RF, Prineas RJ, Jeffery RW, et al. Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients. Am Heart J 1983; 105: 128–33.
21. Reisin E, Frohlich ED, Messerli FH, et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983; 98: 315–9.
22. Andersson of, Fagerberg B, Hedner T. Importance of dietary salt in the hemodynamic adjustment to weight reduction in obese hypertensive men. Hypertension 1984; 6: 814–9.
23. Kimura G, Saito F, Kojima S, et al. Renal function curve in patients with secondary forms of hypertension. Hypertension 1987; 10: 11–5.
24. Guyton achéal. Renal function curve — a key to understanding the pathogenesis of hypertension. Hypertension 1987; 10: 1–6.
25. Scavo D, Borgia C, Iacobelli A. Aspetti di funzione corticosurrenalica nell'obesita'. Nota VI. Il comportamento della secrezione di aldosterone e della escrezione dei suoi metaboliti nel corso di alcune prove dinamiche. Folia Endocrinol 1968; 21: 591–602.
26. Scavo D, Iacobelli A, Borgia C. Aspetti di funzione corticosurrenalica nell'obesita'. Nota V. La secrezione giornaliera di aldosterone. Folia Endocrinol 1968; 21: 577–90.
27. Sowers JR, Whitfield LA, Catania RA, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982; 54: 1181–6.
28. Tuck ML, Sowers JR, Dornfeld L, Whitfield L, Maxwell M. Reduction in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) 1983; 102: 252–7.
29. O'Hare JA, Minaker K, Young JB, Rowe JW, Pallotta JA, Landsberg L. Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men. Clin Res 1985; 33: 441A. abstract.
30. Danforth E Jr, Acheson KJ, Christin L, Ravussin E, Galeazzi RL, Jequier E. A role for the sympathetic nervous system in the regulation of resting and glucose/insulin-stimulated thermogenesis in man. Clin Res 1987; 35: 501A. abstract.
31. Rocchini AP, Katch V, Schork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987; 10: 267–73.
32. Dustan HP. Mechanisms of hypertension associated with obesity. Ann Intern Med 1983; 98: 860–4.
33. Rocchini AP, Moorehead C, Wentz E, Deremer S. Obesity-induced hypertension in the dog. Hypertension 1987; 9: Suppl III: III-64–III-68.
34. Krotkiewski M, Mandroukas K, Sjostrom L, Sullivan L, Wetterqvist H, Bjorntrop P. Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 1979; 28: 650–8.
35. Golay A, Felber JP, Dusmet M, Gomez F, Curchod B, Jequier E. Effect of weight loss on glucose disposal in obese and obese diabetic patients. Int J Obes 1985; 9: 181–91.
36. Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin: characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest 1962; 41: 2173–81.
37. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986; 62: 1302–4.
38. Lucus CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension 1985; 7: 702–6.
39. Gill JR Jr, Güllner HG, Lake CR, Lakatua DJ, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988; 11: 312–9.
40. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982; 21: 371–8.
41. Koolen MI, van Brummelen P. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 1984; 6: 820–5.
42. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809–17.
43. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7.
44. Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med 1986; 80: 861–4.
45. Rose HG, Yallow RS, Schweitzer P, Schwartz E. Insulin as a potential factor influencing blood pressure in amputees. Hypertension 1986; 8: 793–800.